New Salonpas(R) DEEP Relieving Gel: A Powerful Topical Analgesic Innovation

New Salonpas(R) DEEP Relieving Gel: A Powerful Topical Analgesic Innovation 
FLORHAM PARK, NJ -- (Marketwired) -- 07/22/13 --  Hisamitsu America,
a division of Hisamitsu Pharmaceutical Co., Inc., and the
manufacturers of Salonpas(R), the one and only OTC pain patch that is
FDA approved and clinically proven, maintains their commitment to
providing industry leading, topical analgesic solutions with the
launch today of Salonpas(R) DEEP Relieving Gel.  
"Transdermal creams, gels, foam and patches offer a unique way of
delivering medication to your body which offers significant
advantages over taking medications orally," says Dr. Sylvia Hesse,
who is an orthopedic medicine specialist at Manhattan Spine & Sports
Medicine. "One of the biggest advantages is that the medication is
delivered directly to the site of pain. Direct application allows a
higher concentration of the drug to reach the tissue that needs it.
The total amount of medication absorbed into the bloodstream is low,
leading to a very low incidence of side effects, in contrast to oral
medications. Topical treatments can use less medicine and get the
same or better relief." 
"While many Americans still turn to over-the-counter pills to relieve
pain, topical analgesic pain relief is gaining greater market
recognition and we are proud to bring to market solutions that are
well-tested and manufactured to the highest quality," said John
Incledon, President & CEO, Hisamitsu America.  
New Salonpas(R) DEEP Relieving Gel is available at leading retailers
nationwide. Designed to penetrate deep to relieve the toughest muscle
and joint pain, Salonpas(R) DEEP Relieving Gel is an easy-to-use
topical analgesic that starts to delivers pain relief in seconds.
With three active ingredients, camphor (3.1%), menthol (10%) and
methyl salicylate (15%), DEEP Relieving Gel rushes strong medicine
where you need it in a fast-melting, quick-absorbing, clear,
non-greasy formulation. 
About Hisamitsu America:
 Hisamitsu America is the US division of
Hisamitsu Pharmaceutical Co., Inc., founded in 1847, which has
specialized in topical drug delivery technology since the
introduction of its Salonpas line of patches in 1934. The SALONPAS(R)
product line, which gained early acceptance in Asia and now sells in
50 countries, has pioneered the development of topicalpatches to
relieve everyday aches and pains. Today, the Salonpas(R) Pain Relief
Patches are the first and only FDA-approved OTC pain patch. For more
information, visit www.salonpas.us. 
Image Available: http://www2.marketwire.com/mw/frame_mw?attachid=2356374 
Media contact:
Nancy Tamosaitis
Vorticom, Inc.
212.532.2208 
nancyt@vorticom.com 
 
 
Press spacebar to pause and continue. Press esc to stop.